Skip to main content
. Author manuscript; available in PMC: 2010 Apr 12.
Published in final edited form as: Cancer Lett. 2007 May 17;255(1):95–106. doi: 10.1016/j.canlet.2007.03.025

Table 1.

Arsenic-binding proteins in MCF-7 cells identified by MALDI-MS

Name MW (Da) Total
score1
No. of
Peptides
matched
Function
Tubulin β2 2 49,799 990 33 Structural subunit of microtubules
Tubulin β5 2 49,639 974 40 Structural subunit of microtubules
Hsp 90β 3 83,081 961 25 Stress response
Pyruvate kinase M2 (PKM2) 57,746 723 19 Glycolysis
HnRNP K 50,944 644 27 Mitochondria-related protein
Phosphoglycerate kinase 1 44,568 599 13 Glycolysis
Pyruvate carboxylase 129,551 552 12 Glyconeogenesis and lipogenesis
Neural enolase 47,008 516 12 Glycolysis
β-tubulin 2 50,004 474 19 Structural subunit of microtubules
β-tubulin-1 2 41,465 465 15 Structural subunit of microtubules
Transketolase 67,835 425 16 Pentose phosphate cycle
D-3-phosphoglycerate dehydrogenase 56,614 419 7 Amino acid biosynthesis
β-actin 2 41,648 397 14 Cytoskeleton
Malate dehydrogenase 35,509 360 9 Tricarboxylic acid cycle
Ubiquitin-activating enzyme E1 117,774 321 8 Proteolysis
6-phosphogluconate dehydrogenase 52,975 319 9 Pentose phosphate cycle
Filamin A 280,586 311 8 Cytoskeleton
T-complex protein 1, theta subunit 59,582 301 7 Stress response
Glyceraldehyde-3-phosphate dehydrogenase 35,899 258 8 Glycolysis
Importin 90 97,108 248 7 Nuclear import
Annexin II 38,449 226 5 Phospholipids-binding protein
Cytokeratin 2-1 65,847 216 4 Late cytoskeletal intermediate filament
Lactate dehydrogenase B chain 36,484 176 4 Glycolysis
ATP synthase alpha chain 59,714 174 3 Mitochondrial ATP synthesis
Hsp27 3 22,768 158 3 Stress response
Elongation factor 2 95,146 146 3 Protein biosynthesis
Puromycin-sensitive aminopeptidase 103,237 140 3 Aminopeptidase
HnRNP C1/2 33,667 137 3 Mitochondrial protein
Nucleolar protein p120 94,020 131 3 Ribonucleoprotein
GTP-binding nuclear protein RAN 24,408 122 3 Nucleocytoplasmic transport
Ribophorin I (glycosylation) 68,527 121 3 Protein amino acid glycosylation
DNA replication licensing factor MCM6 92,831 107 3 DNA replication
Eukaryotic translation initiation factor 4A1/2 46,125 99 3 Protein translation
Protein disulfide isomerase precursor 2 57,081 97 3 Stress response
ATP-AMP transphosphorylase 2 26,330 71 3 Adenylate kinase
Proteasome subunit alpha type 6 27,382 70 3 Proteolysis
Rho GDP-dissociation inhibitor 1 23,193 56 3 GDP/GTP exchange
Triosephosphate isomerase 26,522 140 2 Isomerase
Clathrin heavy chain 1 191,493 112 2 Coated pits and vesicles
Methylcrotonyl-CoA carboxylase alpha chain 80,382 102 2 Leucine catabolism
14-3-3 protein tau 27,747 105 2 Adapter protein
Tumor rejection antigen 1 (GRP94) 3 92,411 94 2 Stress response
HnRNP A2/B1 37,407 90 2 Mitochondrial protein
Cytokeratin e2 65,825 84 2 Cytoskeleton
Elongation factor 1-delta 31,103 73 2 Protein biosynthesis
Palmitoyl-protein thioesterase 34,171 78 1 Protein modification
Alpha-actinin 4 104,788 76 1 F-actin cross-linking protein
Hsp70-4 3 94,240 49 1 Stress response
Peroxiredoxin 4 2 30,540 48 1 Redox regulation
T-complex protein 1, delta subunit 57,803 46 1 Stress response
1

Probability based Mowse score is −10*Log(P), where P is the probability that the observed match is a random event. Individual ions scores >45 indicate identity or extensive homology (p<0.05)(http://www.matrixscience.com/).

2

Known arsenic-binding proteins (15, 25). Arsenic has been shown to bind peroxiredoxin-1 (thioredoxin peroxidase 2) (24). Its active site is the redox-active Cys52 oxidized to Cys-SOH. Cys-SOH rapidly reacts with Cys173-SH of the other subunit to form an intermolecular disulfide with a concomitant homodimer formation. Similar to peroxiredoxin-1 in structure and function, peroxiredoxin-4 (thioredoxin peroxidase AO372) has its active site, the redox-active Cys124, oxidized to Cys-SOH. Cys-SOH rapidly reacts with Cys245-SH of the other subunit to form an intermolecular disulfide with a concomitant homodimer formation.

3

Stress response proteins known to be induced by arsenic treatment (37).

HHS Vulnerability Disclosure